By submitting an abstract, you agree to the following:

• The abstract has sound methodology and is ethically approved.
• The abstract is not an advertisement, nor contains anything obscene, defamatory, libellous, unlawful or in any way actionable.
• The abstract will be included on the online conference portal and will be made available on the UK Kidney Week website.
• All authors have seen and approved the abstract as submitted.
• The work has not previously been accepted for publication in a peer-reviewed journal.

Please check carefully for typographical errors, misspellings, poor hyphenation, etc. Please check that your abstract title is correct.

Abstract Title

Word count: maximum 25

The ‘Full title’ should be presented sentence case (not in title case or block capitals), i.e. only the first letter of the title or appropriate terms such as abbreviations or proper nouns should be upper case.

The title of the abstract should encompass the hypothesis you are testing or the nature of your investigation.

Please do not include author details or information that identifies your unit or hospital in the abstract title.

Authors and Affiliations

You will be asked to provide author and affiliation details within the submission process.

Topic

You will be asked to choose the relevant topic for your abstract.

Biography

Word count: Maximum 200

You will be asked to provide a short biography for the lead author.

Abstract Body

Word count: Maximum 500

Please do not include author details or information that identifies your unit or hospital in the body of the abstract.

For QI or case report abstracts, please see sections below for additional formatting advice.

The abstract should follow this format:

• introduction
• methods
• results
• discussion

The first paragraph should concisely outline the background to the research and why the research needed to be undertaken – such as hypothesis testing or lack of data in a certain area.

The second paragraph should detail the methods you have used to generate your data. Full details of non-standard abbreviations should be given the first time it is used.

Methods should flow from the most important/widely used method to the least.

The next section requires clear expression of your results. Quantitative data should always be included with the associated unit of measurement (e.g. ng/ml, % of control), where possible. The use of the word ‘significant’ should only be used in association with data that has been assessed for significance, with P<0.05, using an appropriate statistical test. The nature of the test can be outlined in the poster/oral. A figure or table may be included (see below).

The final section should concisely outline your main findings, either in the form of a summary or a conclusion. Please refrain from stating that further research is necessary.

It is best to type your abstract straight into the online submission form, or alternatively paste the text from a word-processed document.

Tables, figures and references may be included with your abstract. Please see below for instructions on how to add these.

You will be able to submit an abstract under one of the following themes:

Please see the SQUIRE guidelines for QI reporting for more detailed guidance

The abstract should follow this format:

• introduction including a clear aim for the project
• QI methodology used
• results, ideally showing changes in data over time
• discussion – summary of main findings and assessment of how the work can be sustained

The first paragraph should concisely outline why the work was undertaken, for example the practical implementation of a known or new intervention to improve patient care.  It should include a clear project aim.

The second paragraph should concisely outline what you did, for example team structure, baseline data, QI methodology used, how progress was measured over time.  Measurement may be qualitative (eg. surveys) or quantitative (numerical).  The methods should usually be described in time order.  Full details of any non-standard abbreviation should be given the first time it is used.

The next section requires a clear description of the results, including run charts of data where appropriate. Run chart rules or Statistical Process Control (SPC) charts can be used to show signs of real change.  Tables, figures and references may be included.

The final section should concisely outline your main findings with reference to the project aim, and next steps.  The best QI abstracts will often describe the steps taken to ensure the improvement work can be sustained over time, and an assessment of the potential to spread to other healthcare settings.

UKKW will accept case report abstracts for consideration. Case reports that are based on clinico-pathological (kidney biopsy) findings will be eligible for inclusion in the clinic-pathological conference session.

Case Reports should show one or more of the following:

• unexpected or unusual disease presentations
• unreported or unusual side effects
• patient safety considerations
• findings of relevance to pathogenesis
• unusual events during treatment or follow-up
• presentation and management of very rare diseases.

Reports can also comprise:

• N of 1 trials
• meta-analyses of published case reports
• retrospective studies that include case-specific information (age, sex and ethnicity)

Authors are reminded to take particular care to ensure that the submitted case report includes no potential patient identifiers.

Adding figures and tables

Figures and tables can be uploaded as supporting documents, as image files.

Adding references

References do not need to be included.

All abstracts must be submitted online using the EventsAir platform.

If all required abstract submission fields have been completed, you will have the option to submit your abstract at the bottom of the page. If there are any remaining fields or sections to complete you will only have the option to save your submission as a draft until they are completed.

Once you click the 'submit' button, the online submission page will change to a submission confirmation page and you will receive a confirmation email. This may get sent to your junk/spam folder but if you do not receive it, please email events@ukkidney.org.

You will not be able to edit your submitted abstract so please do not submit until you are sure all is correct.

Abstract selection will be the responsibility of the Programme Committee and the submitting author of each abstract will be contacted via the email address given on the submission (unless a different email address is provided).

Late-breaking abstracts cover ground-breaking data that would not otherwise have been presented at UKKW 2025.

If such data are available after the regular abstract deadline, the Programme Committee will still consider it for presentation.

Late-breaking abstracts describe the latest advances, trial data, and results that have not been previously published or presented and highlight novel and practice-changing studies.

The call for late-breaking abstracts is NOT an extension of the general submission deadline.